Spectrum Pharmaceuticals, Inc. to Present Corporate Update at Stifel Nicolaus Healthcare Conference in Boston on September 6th and at BioCentury NewsMakers Conference in New York City on September 7th

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the Company’s business strategy and commercial and development-stage programs will be given at the Stifel Nicolaus Healthcare Conference being held at The Four Seasons Hotel in Boston. The Company presentation is on Thursday, September 06, 2012, at 4:25 PM ET.